ProQR Therapeutics N.V. (PRQR) Stock Sinking in Premarket, Here’s why.
Maria Masood
February 11, 2022
ProQR Therapeutics N.V. (PRQR) creates transformative RNA therapeutics for treating Leber congenital amaurosis 10, retinitis pigmentosa, and Usher syndrome. The company’s pipeline is growing based